Home Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer
 

Keywords :   


Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer

2013-06-25 09:00:00| drugdiscoveryonline News Articles

Seattle Genetics, Inc. recently announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer)

Tags: with collaboration seattle enters

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Tropical Storm Chris Update Statement
01.07Summary for Tropical Storm Chris (AT3/AL032024)
01.07Boeing to get 'sweetheart deal' -victims' lawyer
01.07Tropical Storm Chris Graphics
01.07Hurricane Beryl Forecast Discussion Number 10
01.07Tropical Storm Chris Forecast Discussion Number 2
01.07Tropical Storm Chris Wind Speed Probabilities Number 2
01.07Tropical Storm Chris Public Advisory Number 2
More »